Esperion Therapeutics adopts 2022 Stock Option and Incentive Plan
Esperion Therapeutics filed its 2022 Stock Option and Incentive Plan to encourage employee ownership through equity awards including options, RSUs, and restricted stock. The plan is designed to align employee interests with shareholder value creation across officers, employees, d
View filing at SEC.gov →